Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Pharmaceuticals and Medical Devices Agency (PMDA)
Headquarters: Tokyo, Japan
Website: http://www.pmda.go.jp/english/...
Year Founded: 2004
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Sep 2, 2021
Regulation
China and Japan raise the bar on expedited approvals, adding time limits
Iterating on FDA, EMA expedited approvals with stricter requirements for postmarket data submissions
BioCentury | Oct 7, 2020
Product Development
Oct. 6 Quick Takes: BARDA whistleblower quits NIH; plus COVID-19 updates from Vir-GSK, BioNTech, Pfizer, $115M B round for Talaris and more
Former BARDA Director Bright leaving NIH Rick Bright, the former director of the Biomedical Advanced Research and Development Authority and HHS deputy assistant secretary for preparedness and
BioCentury | Apr 10, 2020
Regulation
Coalition of regulators call coordinated trials key to fighting COVID-19
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Jun 22, 2018
Finance
Regenerating eastward
Belgian regenerative medicine biotech Promethera makes the case for expanding in Asia
BioCentury | Mar 29, 2018
Politics, Policy & Law
Progress preserved
Why industry is balking at Japan’s new pricing reforms
BioCentury | Dec 16, 2017
Regulation
Growth medium
How FDA’s regenerative medicine framework puts the U.S., Japan and Europe on the same page
BioCentury | Apr 28, 2017
Politics, Policy & Law
Access and innovation in Japan
How Japan’s MHLW is grappling with drug pricing, access and innovation
BioCentury | Mar 31, 2017
Regulation
Stuck in the MIDD-le
Why companies want flexibility in guidance on PK modeling tools
Items per page:
1 - 10 of 37